Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
aqueduct of Sylvius, stenosis
aqueductal stenosis
blindness
cataracts
cataracts, congenital
cerebellar hypoplasia
contractures, joint
cornea, opacity of
encephalocele
genetic neurologic disorders
hydrocephalus
hydrocephalus, congenital
hypotonia
joint hypermobility
lissencephaly
malformation, CNS, congenital
micropthalmia
MRI
MRI, abnormal
muscle weakness
muscular dystrophy
muscular dystrophy, central nervous system abnormality
muscular dystrophy, classification
muscular dystrophy, congenital
muscular dystrophy, congenital, Fukuyama type
muscular dystrophy, congenital, Ullrich
neuropathology, brain
psychomotor retardation
retinal detachment
retinal dysplasia
review article
Walker-Warburg syndrome
white matter disease
Showing articles 300 to 350 of 1910 << Previous Next >>

Infections of the Nervous System, (Bacterial, Fungal, Spirochetal, Parasitic) and Sarcoidosis, Neurosyphilis
Adams & Victors Principles of Neurology, Chp 32, pg 723, Ropper, A.H.,et al, 2014

Inherited Metabolic Diseases of the Nervous System, Infantile Gaucher Disease
Adams & Victors Principles of Neurology, Chp 37, pg 958, Ropper, A.H.,et al, 2014

Degenerative Diseases of the Nervous System, Progressive Supranuclear Palsy
Adams & Victors Principles of Neurology, Chp 39, pg 1096, Ropper, A.H.,et al, 2014

Degenerative Diseases of the Nervous System, Machado-Joseph-Azorean Disease
Adams & Victors Principles of Neurology, Chp 39, pg 1107, Ropper, A.H.,et al, 2014

Pharyngeal-Cervical-Brachial Variant of Guillain-Barr� Syndrome
JNNP 85:339-344, Wakerley, B.R. & Yuki, N., 2014

4.5-Hour Time Window for Intravenous Thrombolysis with Recombinant Tissue-Type Plasminogen Activator is Established Firmly
Stroke 45:912-913,916, Schellinger, P.D. & Kohrmann, M., 2014

The 4.5-HourTime Window for Intravenous Thrombolysis with Intravenous Tissue-Type Plasminogen Activator is Not Firmly Established
Stroke 45:915-915,916, Wechsler, L.R., 2014

Preexisting Cerebral Microbleeds on Susceptibility-Weighted Magnetic Resonance Imaging and Post-Thrombolysis Bleeding Risk in 392 Patients
Stroke 45:1684-1688, Gratz, P.P.,et al, 2014

Remote or Extraischemic Intracerebral Hemorrhage - An Uncommon Complication of Stroke Thrombolysis
Stroke 45:1657-1663, Mazya, M.V.,et al, 2014

Reperfusion Therapies for Wake-Up Stroke
Stroke 45:1869-1875, Buck, D.,et al, 2014

Safety of Thrombolysis in Patients with Acute Ischemic Stroke and Cerebral Cavernous Malformations
Stroke 45:1846-1848, Erdur, H.,et al, 2014

Actionable Diagnosis of Neuroleptospirosis by Next-Generation Sequencing
NEJM 370:Doi:10.1056/NEJMoal1401268, Wilson, M.R.,et al, 2014

Unexplained Early Neurological Deterioration After Intravenous Thrombolysis
Stroke 45:2004-2009, Seners, P.,et al, 2014

Immunoglobulin G4-Related Disease of the Orbit: Imaging Features in 27 Patients
AJNR 35:1393-1397, Tiegs-Heiden, C.A.,et al, 2014

Symptomatic Intracerebral Hemorrhage in Acute Ischemic Stroke After Thrombolysis With Intravenous Recombinant Tissue Plasminogen Activator
JAMA Neurol 81:1181-1185, Yaghi, S.,et al, 2014

Number of Cerebral Microbleeds and Risk of Intracerebral Hemorrhage after Intravenous Thrombolysis
Stroke 45:2900-2905, Dannenberg, S.,et al, 2014

Stroke and the Law
Stroke 45:3141-3146, Fisher, M. & Schneider, P., 2014

Tolosa-Hunt Syndrome - a Rare Cause of Headache and Ophthalmoplegia
Lancet 382:912, Zurawski, J. & Akhondi, H., 2013

New Appearance of Extraischemic Microbleeds on T2*-Weighted Magnetic Resonance Imaging 24 Hours After Tissue-Type Plasminogen Activator Administration
Stroke 44:2776-2781, Kimura, K.,et al, 2013

Thrombolysis for Ischemic Stroke Associated with Infective Endocarditis
Stroke 44:2917-2919, Asaithambi, G.,et al, 2013

Painful Ophthalmoplegia Following Dental Procedure
Neuroophthalmol 37:165-168, Simsek, I.,et al, 2013

Safety of Intravenous Thrombolysis for Ischemic Stroke in Patients Treated with Warfarin
Ann Neurol 74:266-274, Mazya, M.V.,et al, 2013

IgG4-Related Orbital Disease and Enlargement of the Trigeminal Nerve Branches
Neurol 81:e117-e118, Deschamps, R.,et al, 2013

Clinicopathologic Conference, Dissection of the left vertebral artery and cerebellar infarction
NEJM 369:1736-1748, Case 34-2013, 2013

Serum Creatinine May Indicate Risk of Symptomatic Intracranial Hemorrhage after Intravenous Tissue Plasminogen Activator (IV tPA)
Medicine 92:317-323, Marsh, E.B.,et al, 2013

Central Nervous System Involvement in Whipple Disease
Medicine 92:324-330, Compain, C.,et al, 2013

IV Thrombolysis and Renal Function
Neurol 81:1780-1788, Gensicke, H.,et al, 2013

Bilirubin-Induced Neurologic Damage - Mechanisms and Management Approaches
NEJM 369:2021-2030, Watchko, J.F.,et al, 2013

Thrombolysis for Acute Ischemic Stroke in Patients with Cancer
Stroke 44:3573-3576, Murthy, S.B.,et al, 2013

Glycosylated Hemoglobin A1 Predicts Risk for Symptomatic Hemorrhage After Thrombolysis for Acute Stroke
Stroke 44:2134-2138, Rocco, A.,et al, 2013

Is Intra-Arterial Thrombolysis Beneficial for M2 Occlusions? Subgroup Analysis of the PROACT-II Trial
Stroke 44:240-242, Rahme, R.,et al, 2013

Prehospital Thrombolysis in Acute Stroke
Neurol 80:163-168, Weber, J.,et al, 2013

An Observational Study of Thrombolysis Outcomes in Wake-Up Ischemic Stroke Patients
Stroke 44:427-431, Manawadu, D.,et al, 2013

Criteria for the Diagnosis of Corticobasal Degeneration
Neurol 80:496-503, Armstrong, M.J.,et al, 2013

Safety of Thrombolysis in Stroke Mimics
Stroke 44:1080-1084, Zinkstok, S.M.,et al, 2013

Endovascular Treatment for Acute Ischemic Stroke-Still Unproven
NEJM 368:952-955, Chimowitz,M., 2013

A Trial of Imaging Selection and Endovascular Treatment for Ischemic Stroke
NEJM 368:914-923,952, Kidwell, C.S.,et al, 2013

Endovascular Therapy after Intravenous t-PA versus t-PA Alone for Stroke
NEJM 368:893-903,952, Broderick, J.P.,et al, 2013

Endovascular Treatment for Acute Ischemic Stroke
NEJM 368:914-923,952, Ciccone, A.,et al, 2013

Treatment of Patients with Suspected Ischemic Stroke of Undetermined Onset and Negative Head Computed Tomography Scan
Stroke 44:1494-1495, Adams, H., 2013

A Plain Computed Tomography Scan is Sufficient to Consider Thrombolysis in Patients with Unknown Time of Onset
Stroke 44:1492-1493, Alexandrov, A., 2013

Computed Tomography Angiography in Hyperacute Ischemic Stroke
Stroke 44:1480-1488, Mortimer, A.,et al, 2013

Negative Diffusion-Weighted Imaging After Intravenous Tissue-Type Plasminogen Activator is Rare and Unlikely to Indicate Averted Infarction
Stroke 44-1629-1634, Freeman, J.,et al, 2013

Thrombolysis Despite Recent Stroke
Stroke 44:1736-1738, Alhazzaa, M.,et al, 2013

Ptosis, Erythema, and Rapidly Decreasing Vision
JAMA 309:2382-2383, Zanation, A.,et al, 2013

Results of Intravenous Thrombolysis within 4.5 to 6 Hours and Updated Results within 3 to 4.5 Hours of Onset of Acute Ischemic Stroke Recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR)
JAMA Neurol 70:837-844, Ahmed, N.,et al, 2013

Comparison of Final Infarct Volumes in Patients who Received Endovascular Therapy or Intravenous Thrombolysis for Acute Intracranial Large-Vessel Occlusions
JAMA Neurol 70:831-836, Rangaraju, S.,et al, 2013

A Case-Controlled Comparison of Thrombolysis Outcomes Between Wake-Up and Known Time of Onset Ischemic Stroke Patients
Stroke 44:2226-2231, Manawadu, D.,et al, 2013

Recurrent Oculomotor Palsies Caused by Neurosarcoidosis
Neurol 26:307-313, Kana, V.,et al, 2013

Thrombolysis of Basilar Artery Occlusion: Impact of Baseline Ischemia and Time
Ann Neurol 73:688-694, Strbian, D.,et al, 2013



Showing articles 300 to 350 of 1910 << Previous Next >>